115 related articles for article (PubMed ID: 11555755)
1. Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells.
Lathers DM; Achille N; Kolesiak K; Hulett K; Sparano A; Petruzzelli GJ; Young MR
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):205-12. PubMed ID: 11555755
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
Pak AS; Wright MA; Matthews JP; Collins SL; Petruzzelli GJ; Young MR
Clin Cancer Res; 1995 Jan; 1(1):95-103. PubMed ID: 9815891
[TBL] [Abstract][Full Text] [Related]
3. Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
Young MR; Wright MA; Pandit R
J Immunol; 1997 Jul; 159(2):990-6. PubMed ID: 9218621
[TBL] [Abstract][Full Text] [Related]
4. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells.
Garrity T; Pandit R; Wright MA; Benefield J; Keni S; Young MR
Int J Cancer; 1997 Nov; 73(5):663-9. PubMed ID: 9398043
[TBL] [Abstract][Full Text] [Related]
5. Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.
Lathers DM; Clark JI; Achille NJ; Young MR
Cancer Immunol Immunother; 2004 May; 53(5):422-30. PubMed ID: 14648070
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients.
Lathers DM; Lubbers E; Wright MA; Young MR
J Leukoc Biol; 1999 May; 65(5):623-8. PubMed ID: 10331490
[TBL] [Abstract][Full Text] [Related]
7. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance.
Strauss L; Volland D; Kunkel M; Reichert TE
Med Sci Monit; 2005 Aug; 11(8):BR280-92. PubMed ID: 16049374
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL
Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
[TBL] [Abstract][Full Text] [Related]
10. Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck.
Kacani L; Wurm M; Schwentner I; Andrle J; Schennach H; Sprinzl GM
Oral Oncol; 2005 Jan; 41(1):17-24. PubMed ID: 15598581
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells and HNSCC: a potential treatment option? (Review).
Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
[TBL] [Abstract][Full Text] [Related]
12. Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally different.
Lathers DM; Lubbers E; Beal NM; Wright MA; Young MR
Hum Immunol; 1999 Dec; 60(12):1207-15. PubMed ID: 10626734
[TBL] [Abstract][Full Text] [Related]
13. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA
Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944
[TBL] [Abstract][Full Text] [Related]
14. Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck.
Sakakura K; Chikamatsu K; Takahashi K; Whiteside TL; Furuya N
Cancer Immunol Immunother; 2006 Feb; 55(2):151-9. PubMed ID: 15889251
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
16. Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
Ferrari S; Rovati B; Porta C; Alessandrino PE; Bertolini A; Collovà E; Riccardi A; Danova M
Cancer Immunol Immunother; 2003 Jun; 52(6):359-66. PubMed ID: 12664135
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
18. CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer.
Pandit R; Lathers DM; Beal NM; Garrity T; Young MR
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):749-54. PubMed ID: 10961808
[TBL] [Abstract][Full Text] [Related]
19. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
20. Protective mechanisms of head and neck squamous cell carcinomas from immune assault.
Young MR
Head Neck; 2006 May; 28(5):462-70. PubMed ID: 16284974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
